ScripThe year gone by had its see-saw moments for the Indian pharmaceutical industry. The arrival of an indigenously developed CAR-T cell therapy in India was among the highlights of 2023, but exports of c
Generics BulletinDr Reddy’s appears to be treading a distinctive path in China, building its long-standing local operations there as well as partnering with Chinese companies to in-license and develop/commercialize k
ScripDr. Reddy's Laboratories Ltd. appears to be treading a distinctive path in China, building its long-standing local operations there as well as partnering with Chinese companies to in-license and deve
Generics BulletinMayne Pharma’s long serving CEOScott Richards intends to step down from the Australian firm, after the chief exec role was shifted to the US on a permanent basis. His departure comes at a strategic c